Propyl paraben

What this is

Under current U.S. federal rules, propyl paraben is still an FDA-recognized food ingredient for antimicrobial use, with food use limited by good manufacturing practice and a stated current maximum of 0.1%. FDA has also placed propylparaben on its post-market risk-and-safety review list, with review initiated in 2024. The main safety debate is reproductive/endocrine relevance: EFSA could not include propyl paraben in the methyl/ethyl paraben group ADI in 2004, and JECFA withdrew its ADI in 2006 because male-rat reproductive findings lacked a clear no-effect level. Later peer-reviewed reviews argue those original findings were not robust and that subsequent rat studies did not reproduce male reproductive toxicity at much higher doses. Regulators therefore disagree: the U.S. still permits limited food uses, while the EU removed E216/E217 from food-additive authorization and several U.S. states have enacted broad retail-food restrictions or bans.

Safety Review

The critical endpoints experts review in safety assessments. This is not a prediction of harm.

FDA still permits limited food use and is reviewing propylparaben, but EFSA could not include it in the methyl/ethyl paraben group ADI and JECFA withdrew its ADI after male-rat reproductive findings. Later reviews report the original findings were not reproduced at higher doses, so reproductive concern remains unresolved rather than proven human harm.